FDA Revokes Authorization of J&J’s Covid Vaccine as Demand Wanes

The Johnson & Johnson Janssen Covid-19 vaccine.

Photographer: Elijah Nouvelage/Bloomberg
Lock
This article is for subscribers only.

US regulators revoked emergency authorization for Johnson & Johnson’s Covid-19 vaccine after the company’s Janssen unit requested its withdrawal.

Janssen informed the Food and Drug AdministrationBloomberg Terminal that shots bought by the government had expired and there was no demand for the product in the US, the regulator said in a statement released last week.